116 related articles for article (PubMed ID: 26125868)
21. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.
Takano M; Lu Z; Goto T; Fusi L; Higham J; Francis J; Withey A; Hardt J; Cloke B; Stavropoulou AV; Ishihara O; Lam EW; Unterman TG; Brosens JJ; Kim JJ
Mol Endocrinol; 2007 Oct; 21(10):2334-49. PubMed ID: 17609436
[TBL] [Abstract][Full Text] [Related]
24. FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
Kojima T; Shimazui T; Horie R; Hinotsu S; Oikawa T; Kawai K; Suzuki H; Meno K; Akaza H; Uchida K
Genes Chromosomes Cancer; 2010 Apr; 49(4):379-89. PubMed ID: 20095040
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of phosphorylated FOXO1 expression in soft tissue sarcoma.
Zhang B; Tomita Y; Ch'ng E; Qiu Y; He J; Jin YF; Tomoeda M; Hamada K; Ueda T; Aozasa K
Ann Surg Oncol; 2009 Jul; 16(7):1925-37. PubMed ID: 19408047
[TBL] [Abstract][Full Text] [Related]
26. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
27. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
[TBL] [Abstract][Full Text] [Related]
28. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
29. Differential response of glioma cells to FOXO1-directed therapy.
Lau CJ; Koty Z; Nalbantoglu J
Cancer Res; 2009 Jul; 69(13):5433-40. PubMed ID: 19549905
[TBL] [Abstract][Full Text] [Related]
30. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
[TBL] [Abstract][Full Text] [Related]
31. Forced FoxO1:S
Piao XY; Li W; Li Z; Zhang N; Fang H; Zahid D; Qu Q
Neurol Res; 2019 Feb; 41(2):189-198. PubMed ID: 30453847
[TBL] [Abstract][Full Text] [Related]
32. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
Fan C; Liu S; Zhao Y; Han Y; Yang L; Tao G; Li Q; Zhang L
Biomed Pharmacother; 2013 Jul; 67(6):521-6. PubMed ID: 23721824
[TBL] [Abstract][Full Text] [Related]
34. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
36. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
Xu D; He X; Chang Y; Xu C; Jiang X; Sun S; Lin J
Oncol Rep; 2013 Feb; 29(2):653-61. PubMed ID: 23151657
[TBL] [Abstract][Full Text] [Related]
39. Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer.
Kim TH; Jo SW; Lee YS; Kim YJ; Lee SC; Kim WJ; Yun SJ
J Korean Med Sci; 2009 Jun; 24(3):468-73. PubMed ID: 19543511
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of FoxM1 inhibits proliferation, invasion and angiogenesis of HeLa cells in vitro and in vivo.
Chen H; Zou Y; Yang H; Wang J; Pan H
Int J Oncol; 2014 Dec; 45(6):2355-64. PubMed ID: 25201015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
